All News | FDA

Advertising & Promotion

Feb 7, 2023
PMCPA Issues UK’s First Guidance on Social Media
Jan 29, 2023
NAD Finds Drug Claim Supported in Physician-Directed Messaging But Not in Consumer-Directed Ads
Jan 25, 2023
DePuy Synthes To Pay $9.75 Million To Resolve Allegations of Providing Free Devices to Surgeon
Jan 24, 2023
Physicians’ Group Files OPDP Complaint Over 60 Minutes’ Wegovy Segment
Jan 13, 2023
Omnibus Spending Act Codifies FDA Guidance on Communications with Payors
Jan 6, 2023
Arizona Sues Drug Maker Over Potency Statements
Dec 30, 2022
FTC Expands Advertising Guide To Include All Health-Related Claims
Dec 23, 2022
Florida Supreme Court Considers Grand Jury Investigation of Manufacturers’ COVID-19 Vaccine Claims
Dec 19, 2022
FDA: Ads for Hypertension Drugs Should Cite Cardiovascular Outcome Claims
Dec 15, 2022
PMCPA Finds Novo Nordisk Breached ABPI Code in Weight Management Course Sponsorship

Good Clinical Practice

Apr 25, 2023
FDA Debars Former Trial Site Co-Owner
Apr 18, 2023
FDA Now Recommends Risk-Based Monitoring for Clinical Trials
Apr 13, 2023
FDA, OHRP Tell Sponsors How To Navigate Agency Pediatric Research Referrals
Mar 31, 2023
Clinical Investigators Receive Warning Letters Over Lack of IND and Not Following Protocol
Mar 24, 2023
FDA Extensively Revises Clinical Trial Electronic Records Guidance
Mar 17, 2023
Sponsor-Investigator Receives Warning Letter for Failing to Submit an IND
Mar 13, 2023
FDA BIMO Inspections Rebound in FY 2022
Mar 9, 2023
FDA Provides Roadmap for Externally Controlled Trials
Mar 1, 2023
Group Petitions FDA To Improve Enforcement of Trial Reporting Mandates
Feb 22, 2023
GAO Recommends More Oversight of IRBs

U.S. Food Labeling

FDA Regulation & Enforcement

Apr 30, 2025
Doctor Faces Up to Three Years in Prison for Administering Non-FDA-Approved Semaglutide to Patients
Apr 25, 2025
FDA Moves To Remove All Petroleum-Based Dyes From Food
Apr 23, 2025
Florida Man Pleads Guilty to Wire Fraud in Connection With Distribution of Black-Market HIV Drugs
Apr 18, 2025
Menendez Reintroduces Caffeine Labeling Bill
Apr 16, 2025
Study Finds Meat-like Names for Plant-based Products Could Confuse Consumers
Apr 16, 2025
Fifth Circuit: Maker of FDA-Approved Drug May Sue Compounder Under State Unfair Competition Statutes
Apr 15, 2025
Vanda Pharmaceuticals Challenges Constitutionality of FDA's Restrictions on Off-Label Marketing
Apr 9, 2025
Firm To Pay $550K To Resolve False Claims Allegations Linked to Multiple Uses of Single-Use Devices
Apr 4, 2025
OPDP Flags Efficacy Webpage With Untitled Letter
Apr 2, 2025
Diopsys Inc. To Pay Up to $14.25 Million To Resolve False Claims Allegations Involving Vision Testing

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.